ArticleOncoimmunology2021

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma.

Soheila Shirinbak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.